Close

Ultragenyx Pharma (RARE) Announces Positive Interim Data from KRN23 Phase 2 in TIO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Ultragenyx Pharma (RARE) Announces Positive Interim Data from KRN23 Phase 2 in TIO

Leerink Lifts PT on Ultragenyx Pharma (RARE) to $94 Amid Solid KRN23 Data in XLH

September 19, 2016 3:48 PM EDT

Leerink boosts its price target on Ultragenyx Pharma (Nasdaq: RARE) from $85 to $94 after the company announced... More